14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Nov 02, 2023 $3.92 $4.04 $3.78 $3.88 5 530 585
Nov 01, 2023 $3.84 $3.97 $3.74 $3.87 4 305 481
Oct 31, 2023 $3.65 $3.84 $3.53 $3.82 4 312 160
Oct 30, 2023 $3.55 $3.80 $3.55 $3.70 4 384 652
Oct 27, 2023 $3.77 $3.77 $3.47 $3.50 4 271 647
Oct 26, 2023 $3.66 $3.79 $3.63 $3.70 4 166 564
Oct 25, 2023 $4.00 $4.02 $3.68 $3.68 4 696 821
Oct 24, 2023 $3.51 $3.96 $3.51 $3.94 8 374 308
Oct 23, 2023 $3.33 $3.49 $3.27 $3.45 5 264 102
Oct 20, 2023 $3.30 $3.39 $3.27 $3.33 3 597 610
Oct 19, 2023 $3.29 $3.34 $3.21 $3.30 6 275 372
Oct 18, 2023 $3.65 $3.65 $3.34 $3.34 5 807 648
Oct 17, 2023 $3.56 $3.79 $3.55 $3.63 7 308 671
Oct 16, 2023 $3.71 $3.71 $3.40 $3.57 6 594 069
Oct 13, 2023 $3.61 $3.73 $3.56 $3.63 4 574 209
Oct 12, 2023 $3.91 $3.91 $3.59 $3.63 6 221 356
Oct 11, 2023 $4.10 $4.18 $3.79 $3.91 5 387 161
Oct 10, 2023 $4.01 $4.18 $3.98 $4.10 5 729 464
Oct 09, 2023 $4.00 $4.06 $3.88 $3.98 5 662 095
Oct 06, 2023 $4.09 $4.18 $3.98 $4.04 5 757 668
Oct 05, 2023 $4.10 $4.25 $4.01 $4.18 4 873 703
Oct 04, 2023 $4.25 $4.29 $4.07 $4.09 4 050 451
Oct 03, 2023 $4.45 $4.60 $4.25 $4.29 3 785 127
Oct 02, 2023 $4.55 $4.59 $4.37 $4.43 4 433 116
Sep 29, 2023 $4.58 $4.66 $4.50 $4.55 3 736 450
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT